Profile ready
Bio · photo · LinkedIn
Profile complete: bio, photo and LinkedIn URL added.
Verified advisor
Not yet earned
Book a Verified Advisor session with a Boardio expert to earn this badge.
Active advisor
No recent applications
Apply to an opportunity to earn this badge. Resets if no activity for 6 months.
About
PhD | MBA | GAICD
Biotech and Pharma
MedTech
Governance
Business Strategy
Deep Tech Commercialisation
Dr. Kerstin Schütz is a highly accomplished Executive and Non-Executive Director, recognised for her strategic leadership and ability to drive innovation at the intersection of science, industry, and technology. She is a trailblazer in science-driven innovation, with a mission to translate breakthrough research into real-world impact. With a PhD in Biophysics and an MBA from Melbourne Business School, she brings a rare blend of technical depth and strategic insight to the biotech, MedTech, and Pharma sectors.
Kerstin has worked across Europe, the US, and Australia in leadership roles with global pharmaceutical firms, cutting-edge start-ups, and national innovation programs. She currently supports entrepreneurs through Australia’s Industry Growth Program and serves as a Technology Commercialisation Coach for early-stage ventures through programs such as MedTech Actuator and the federal government’s Industry Growth Program.
A passionate mentor and ecosystem builder, Kerstin also sits on the Investment Review Committee for the Walter and Eliza Hall Institute’s 66ten Fund — the country’s largest research investment fund — guiding early-stage biotech ventures toward success. Her strength lies in connecting people, science, and capital. Whether advising boards, championing founders, or unlocking funding pathways, Kerstin is a catalyst for turning ideas into impact.
Kerstin currently serves on a range of boards and advisory committees, including:
- Walter Eliza Hall Institute’s 66ten Investment Review Committee
- South Australian Government’s Seed-Start Investment Assessment Panel
- Westmead Institute of Medical Research (WIMR) IP & Commercialisation Committee
- Medical Device Partnering Program (MDPP) Independent Assessment Panel
- Bridge Program Steering Committee
- AusBiotech SA Committee
Biotech and Pharma
MedTech
Governance
Business Strategy
Deep Tech Commercialisation
Dr. Kerstin Schütz is a highly accomplished Executive and Non-Executive Director, recognised for her strategic leadership and ability to drive innovation at the intersection of science, industry, and technology. She is a trailblazer in science-driven innovation, with a mission to translate breakthrough research into real-world impact. With a PhD in Biophysics and an MBA from Melbourne Business School, she brings a rare blend of technical depth and strategic insight to the biotech, MedTech, and Pharma sectors.
Kerstin has worked across Europe, the US, and Australia in leadership roles with global pharmaceutical firms, cutting-edge start-ups, and national innovation programs. She currently supports entrepreneurs through Australia’s Industry Growth Program and serves as a Technology Commercialisation Coach for early-stage ventures through programs such as MedTech Actuator and the federal government’s Industry Growth Program.
A passionate mentor and ecosystem builder, Kerstin also sits on the Investment Review Committee for the Walter and Eliza Hall Institute’s 66ten Fund — the country’s largest research investment fund — guiding early-stage biotech ventures toward success. Her strength lies in connecting people, science, and capital. Whether advising boards, championing founders, or unlocking funding pathways, Kerstin is a catalyst for turning ideas into impact.
Kerstin currently serves on a range of boards and advisory committees, including:
- Walter Eliza Hall Institute’s 66ten Investment Review Committee
- South Australian Government’s Seed-Start Investment Assessment Panel
- Westmead Institute of Medical Research (WIMR) IP & Commercialisation Committee
- Medical Device Partnering Program (MDPP) Independent Assessment Panel
- Bridge Program Steering Committee
- AusBiotech SA Committee
